The form 4 insider filings filtered down by excluding short % float >1%, no identifiable micro cap value institutions, price > .25, Market capitalization less than 250M, exclude industries in finance, biomedical
Only two ideas out of over 100 form 4 filings. ; CWGL, CDNA
Crimson Wine Group, Ltd. (CWGL) "together with its subsidiaries produces & markets wines. It has vineyards in the Napa Valley, Edna Valley in California, Sonoma County, the Willamette Valley in Oregon & Horse Heaven Hills in Washington." Morningstar
Crimson is a stock if after additional research accumulate patiently and wait.
Relatively small insider buying for the week ending 04/22/15.Strong value institutional ownership from Michael Price, Tenton Mighty Mites, Gamco, Perritt.Price reported adding shares at higher market price for the quarter ending 12/31/15
Positives: Diverse group of successful micro cap value institutions purchasing shares greater than current market price. Positive insider buying during 2016 and 2015.High Piotroski F Score of 7.
Revenue per share growth, 5 year annual per share revenue growth rate 18.80%, one year 4.90%.
Per share value improvements for metrics in table below, EBIT, BV, EBITDA.
Gross margins out performing its relative and historical returns, 2010 = 38.48%, 2012 = 49.39%,TTM = 53.25%.
Stable share count 2011 24.46M shares outstanding TTM = 24.23M
Financially sound based on Z score, Sloan and Bennish ratio.
Insider ownership is 31.20%
Market Cap: 208.38M ,Enterprise Value: 182.02M
Price/Sales (ttm): 3.45 , Price/Book (mrq): 1.01
Enterprise Value/Revenue (ttm): 3.02 , Enterprise Value/EBITDA (ttm): 11.87
Profit Margin (ttm): 6.91% , Operating Margin (ttm): 13.22%
Revenue (ttm): 60.23M
Gross Profit (ttm): 32.53M , EBITDA (ttm): 15.34M
Total Cash (mrq): 27.64M , Total Cash Per Share (mrq): 1.13
Total Debt (mrq): 0.00
Current Ratio (mrq): 6.60 , Book Value Per Share (mrq): 8.43
Operating Cash Flow (ttm): 7.74M
52-Week Change3: -7.03%
52-Week High (May 8, 2015)3: 9.80 , 52-Week Low (Feb 17, 2016)3: 7.58
Shares Outstanding: 24.23M , Float: 19.69M
% Held by Insiders: 31.12% , % Held by Institutions1: 20.20%
CareDx, Inc (CDNA) " is a commercial stage company. The Company develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime."
Market Cap : 58.30M , Enterprise Value : 33.85M
Price/Sales (ttm): 1.82 , Price/Book (mrq): 1.58
Enterprise Value/Revenue (ttm): 1.15
Revenue (ttm): 29.45M ,Revenue Per Share (ttm): 2.49
Qtrly Revenue Growth (yoy): 7.50% , Gross Profit (ttm): 17.87M
EBITDA (ttm): -6.73M
Total Cash (mrq): 33.95M , Total Cash Per Share (mrq): 2.85
Total Debt (mrq): 15.80M ,Total Debt/Equity (mrq): 46.59
Current Ratio (mrq): 3.63 , Book Value Per Share (mrq): 2.85
Operating Cash Flow (ttm): -6.50M , Levered Free Cash Flow (ttm): -4.24M
52-Week Change: -16.12%
52-Week High (Jul 13, 2015)3: 8.00
52-Week Low (Sep 29, 2015)3: 3.70
Shares Outstanding: 13.34M , Float: 5.70M
% Held by Insiders: 34.40% , % Held by Institutions: 39.90%
Short % of Float (as of Mar 31, 2016): 0.57%
Royce, Tenton were adding shares for the quarter reported 12/31/15. GABELLI also owns shares.